NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions
In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes
NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection
ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs
Remaining DCT Recompetitions
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?